Tigermed (Stock code: 300347.SZ/3347.HK) is a leading global provider of integrated research and development solutions for
biopharmaceutical and medical device industry. With a broad portfolio of services and a promise of quality, from preclinical devel-
opment to clinical trial to commercialization, we are committed to moving our customers through their development journey
efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 180 service
locations, with over 10,000 employees across 50 countries in Asia Pacific, Europe, North & South America and Africa. We are
devoted to building an integrated platform that enables the boundless possibilities for the healthcare industry, embracing challeng-
es to fulfill our commitment to serving unmet patients’ needs, and ultimately saving lives.